Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …

Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is increasing
worldwide, but striking geographical differences are observed for both risk factors and …

Although the general idea of 'burden'of a disease to a community seems fairly
straightforward, there are multiple dimensions in which it may be expressed, either in terms …

Hepatocellular carcinoma (HCC) is ranked as the 5 th common type of cancer worldwide
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major
changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy …

Background: It is not established whether virological status affects the efficiency of α-
fetoprotein (AFP) as a hepatocellular carcinoma (HCC) marker among patients with chronic …

Purpose: To review information on the use of laboratory tests in screening, diagnosis, and
monitoring of acute and chronic hepatic injury. Data Sources and Study Selection: A …

Hepatocellular carcinoma (HCC) is a potential target for cancer surveillance (or screening)
as it occurs in well‐defined, at‐risk populations and curative therapy is possible only for …